In partnership with Ablatotech, we are developing a patented small molecule regimen that we believe will be a game-changer in Alzheimer’s disease and other dementias.
While other drug discovery companies are wasting a lot of time and resources with the high throughput method of small molecule drug discovery, which is mostly responsible for the ridiculous drug prices today, we prefer a smarter medicinal anthropology approach. In our approach, we start with a single compound, as opposed to thousands or millions of compounds, and develop it into a patented drug. Our approach is more likely to yield drugs that work better and also have a better safety profile.